The FDA's Vaccines and Related Biological Products Advisory Committee endorsed Moderna's seasonal mRNA influenza vaccine in June 2026, resolving the regulatory pathway after earlier public controversy. The endorsement represents the first seasonal mRNA flu vaccine to reach this approval milestone. — Photo by Maksim Goncharenok on Pexels (Pexels License)
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.
